Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted and appeared in  GLP-1GLP-1 Special Editions May 2014

GLP-1 Analog Special Edition, May 2014

Way back in July 2011 we reviewed some of the emerging data showing that the GLP-1 RA class might have some value in improving cardiovascular outcomes. As newer entities in this class have been researched the cardiovascular studies required for approval and aftermarket monitoring continue to show the value of GLP-1 mimetics in improving cardiovascular outcomes. This month I have prepared an update to that report we issued to you back in 2011 and I encourage you to bring yourself up to speed by reviewing this newer data.



Bookmark and Share | Print | Category | Home

This article originally posted 26 May, 2014 and appeared in  GLP-1GLP-1 Special Editions May 2014

Past five issues: Diabetes Clinical Mastery Series Issue 242 | Issue 782 | GLP-1 Special Editions May 2015 | Diabetes Clinical Mastery Series Issue 241 | issue 781 |

Cast Your Vote
Do you believe that the FDA takes too much time to approve a drug?

Search Articles On Diabetes In Control